Serum cholinesterase is associated with incident diabetic retinopathy: the Shanghai Nicheng cohort study
暂无分享,去创建一个
Qiang Wu | X. Hou | Rong Yu | Xiangning Wang | Y.-Z. Bao | Keqing Dong | Xiaoqi Ye | Lili Jia | Weiping Jia | Zhijun Zhu
[1] E. Huang,et al. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes-2022. , 2021, Diabetes care.
[2] E. Huang,et al. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. , 2021, Diabetes care.
[3] J. Bai,et al. Ghrelin Ameliorates Diabetic Retinal Injury: Potential Therapeutic Avenues for Diabetic Retinopathy , 2021, Oxidative medicine and cellular longevity.
[4] A. Bhatwadekar,et al. Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment , 2021, Clinical interventions in aging.
[5] D. Shen,et al. A deep learning system for detecting diabetic retinopathy across the disease spectrum , 2021, Nature Communications.
[6] J. Stewart,et al. Sex-Based Analysis of Potential Inflammation-Related Protein Biomarkers in the Aqueous Humor of Patients With Diabetes Mellitus , 2021, Translational vision science & technology.
[7] Tueng T. Shen,et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study , 2020, The Lancet. Global health.
[8] L. Rashed,et al. Retinoprotective effect of donepezil in diabetic mice involves mitigation of excitotoxicity and activation of PI3K/mTOR/BCl2 pathway. , 2020, Life sciences.
[9] Fan Hu,et al. Nomogram-Based Prediction of the Risk of Diabetic Retinopathy: A Retrospective Study , 2020, Journal of diabetes research.
[10] Jennifer I. Lim,et al. Diabetic Retinopathy Preferred Practice Pattern®. , 2019, Ophthalmology.
[11] Qifu Li,et al. Standards of medical care for type 2 diabetes in China 2019 , 2019, Diabetes/metabolism research and reviews.
[12] Alan W. Stitt,et al. Neurodegeneration in diabetic retinopathy: does it really matter? , 2018, Diabetologia.
[13] Y. Bao,et al. Abdominal subcutaneous adipose tissue: a favorable adipose depot for diabetes? , 2018, Cardiovascular Diabetology.
[14] M. Mesulam,et al. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. , 2018, Brain : a journal of neurology.
[15] E. Finkelstein,et al. Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes , 2017, JAMA.
[16] A. Dunah,et al. Anti-inflammatory effects of astroglial α7 nicotinic acetylcholine receptors are mediated by inhibition of the NF-κB pathway and activation of the Nrf2 pathway , 2017, Journal of Neuroinflammation.
[17] Venkata Ravi Gutlapalli,et al. Anticeramide antibody and butyrylcholinesterase in peripheral neuropathies , 2017, Journal of Clinical Neuroscience.
[18] C. Rochitte,et al. Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial. , 2017, JCI insight.
[19] Jennifer K. Sun,et al. Diabetic Retinopathy: A Position Statement by the American Diabetes Association , 2017, Diabetes Care.
[20] Noemi Lois,et al. The progress in understanding and treatment of diabetic retinopathy , 2016, Progress in Retinal and Eye Research.
[21] R. León,et al. Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection. , 2015, Biochemical pharmacology.
[22] E. Oda. Associations between serum cholinesterase and incident hyper-LDL cholesterolemia, hypertriglyceridemia and hypo-HDL cholesterolemia as well as changes in lipid levels in a health screening population. , 2015, Atherosclerosis.
[23] K. K. Sato,et al. Serum butyrylcholinesterase and the risk of future type 2 diabetes: the Kansai Healthcare Study , 2014, Clinical endocrinology.
[24] C. Casanova,et al. Acetylcholinesterase inhibition promotes retinal vasoprotection and increases ocular blood flow in experimental glaucoma. , 2013, Investigative ophthalmology & visual science.
[25] F. Contaldo,et al. Butyrylcholinesterase as a prognostic marker: a review of the literature , 2012, Journal of cachexia, sarcopenia and muscle.
[26] M. Schneck,et al. Neurodegenerative differences in the retinas of male and female patients with type 2 diabetes. , 2012, Investigative ophthalmology & visual science.
[27] Norbert Pfeiffer,et al. Identification of the muscarinic acetylcholine receptor subtype mediating cholinergic vasodilation in murine retinal arterioles. , 2011, Investigative ophthalmology & visual science.
[28] Ciro Costagliola,et al. Predicting the risk of diabetic retinopathy in type 2 diabetic patients. , 2011, Journal of diabetes and its complications.
[29] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[30] Michael J. Pencina,et al. Comments on ‘Integrated discrimination and net reclassification improvements—Practical advice’ , 2008 .
[31] M. Schetinger,et al. Serum cholinesterase activity in diabetes and associated pathologies. , 2006, Diabetes research and clinical practice.
[32] M. Mathews,et al. Relationship between serum butyrylcholinesterase and the metabolic syndrome. , 2005, Clinical biochemistry.
[33] C. Delporte,et al. Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. , 2004, Endocrinology.
[34] Matthew D. Davis,et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. , 2003, Ophthalmology.
[35] M. Mesulam,et al. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine , 2002, Neuroscience.
[36] S. Brimijoin,et al. Butyrylcholinesterase in Human Brain and Acetylcholinesterase in Human Plasma: Trace Enzymes Measured by Two‐Site Immunoassay , 1988, Journal of neurochemistry.
[37] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[38] G. Siest,et al. Total cholinesterase in plasma: biological variations and reference limits. , 1985, Clinical chemistry.
[39] M. Pencina,et al. A SAS ® Macro to Compute Added Predictive Ability of New Markers Predicting a Dichotomous Outcome , 2010 .
[40] Y. Terauchi,et al. Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance. , 2007, Internal medicine.
[41] S. Patel,et al. Relationship between age and plasma esterases. , 2001, Age and ageing.
[42] A. Vitelli,et al. [Epidemiology of diabetic retinopathy]. , 1988, Minerva endocrinologica.